CATALOGO DEI PRODOTTI DELLA RICERCA

IDOLAZZI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.100
EU - Europa 8.781
AS - Asia 6.146
SA - Sud America 854
Continente sconosciuto - Info sul continente non disponibili 359
AF - Africa 173
OC - Oceania 14
Totale 26.427
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.898
RU - Federazione Russa 3.023
SG - Singapore 2.346
GB - Regno Unito 2.155
CN - Cina 1.961
IT - Italia 987
BR - Brasile 671
DE - Germania 641
SE - Svezia 487
VN - Vietnam 474
HK - Hong Kong 450
FR - Francia 432
IE - Irlanda 394
FI - Finlandia 268
BD - Bangladesh 194
KR - Corea 186
IN - India 121
TR - Turchia 102
JP - Giappone 101
CA - Canada 98
UA - Ucraina 90
AR - Argentina 73
NL - Olanda 72
MX - Messico 51
PL - Polonia 43
ZA - Sudafrica 43
NG - Nigeria 42
ES - Italia 38
ID - Indonesia 37
BE - Belgio 31
AT - Austria 30
EC - Ecuador 28
IQ - Iraq 25
CO - Colombia 21
RO - Romania 20
UZ - Uzbekistan 19
VE - Venezuela 18
SA - Arabia Saudita 17
EG - Egitto 16
IR - Iran 14
CL - Cile 13
PK - Pakistan 13
KE - Kenya 12
MA - Marocco 12
PE - Perù 12
PY - Paraguay 11
AU - Australia 10
BJ - Benin 10
PH - Filippine 10
JM - Giamaica 9
AE - Emirati Arabi Uniti 7
GR - Grecia 7
NP - Nepal 7
QA - Qatar 7
AZ - Azerbaigian 6
CH - Svizzera 6
CR - Costa Rica 6
CZ - Repubblica Ceca 6
ET - Etiopia 6
IL - Israele 6
LT - Lituania 6
SN - Senegal 6
SV - El Salvador 6
TN - Tunisia 6
AL - Albania 5
GT - Guatemala 5
JO - Giordania 5
NO - Norvegia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
EU - Europa 4
HN - Honduras 4
HR - Croazia 4
KG - Kirghizistan 4
LB - Libano 4
MY - Malesia 4
PA - Panama 4
TG - Togo 4
AM - Armenia 3
BG - Bulgaria 3
BY - Bielorussia 3
CU - Cuba 3
DK - Danimarca 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
PT - Portogallo 3
RS - Serbia 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
UY - Uruguay 3
AF - Afghanistan, Repubblica islamica di 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
BW - Botswana 2
GD - Grenada 2
IS - Islanda 2
Totale 26.036
Salva come PNG Salva come JPEG
Città #
Southend 1.927
Dallas 1.579
Singapore 1.279
Ashburn 1.092
Moscow 1.019
Chandler 942
San Jose 874
Jacksonville 473
Hong Kong 438
Council Bluffs 415
Dublin 393
Woodbridge 390
Ann Arbor 315
Beijing 315
Verona 292
The Dalles 274
Houston 217
Los Angeles 182
New York 177
Lawrence 160
Princeton 160
Wilmington 156
Ho Chi Minh City 151
Jinan 145
Bologna 132
Redmond 128
Shenyang 127
Nanjing 122
Hanoi 108
Helsinki 97
Buffalo 90
Tokyo 90
Milan 84
Munich 83
Hebei 73
Santa Clara 73
Tianjin 73
São Paulo 67
Redondo Beach 57
Zhengzhou 56
Rome 53
Changsha 52
Haikou 51
Ningbo 51
Columbus 46
Sindelfingen 43
Taizhou 43
Hangzhou 42
Chicago 41
Guangzhou 41
Orem 41
Abuja 40
Taiyuan 39
Nanchang 38
Montreal 36
San Francisco 36
Warsaw 36
Redwood City 34
Jiaxing 32
Denver 31
London 31
Atlanta 30
Brooklyn 29
Seattle 29
Toronto 28
Brussels 26
Turku 26
Johannesburg 25
Norwalk 25
Phoenix 25
Boardman 24
Lanzhou 24
Washington 24
Fuzhou 23
Hyderabad 23
Amsterdam 22
Da Nang 22
Düsseldorf 21
Chennai 20
Manchester 20
Rio de Janeiro 20
Brasília 19
Dearborn 19
Frankfurt am Main 19
Mexico City 19
Vienna 19
Poplar 18
Sanayi 18
Stockholm 18
Tashkent 18
Haiphong 17
Lancaster 17
Venice 17
Belo Horizonte 15
Boston 15
Falls Church 15
Jakarta 15
Nürnberg 15
Orani 15
Porto Alegre 15
Totale 16.491
Salva come PNG Salva come JPEG
Nome #
Italian Multicenter Real-World Study on the Twelve-Month Effectiveness, Safety, and Retention Rate of Guselkumab in Psoriatic Arthritis Patients 403
First-line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING-SIR registry 367
Teriparatide and denosumab combination therapy and skeletal metabolism 353
A new instrument for the screening of psoriatic arthritis among psoriatic patients 337
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 257
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 257
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 247
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 230
Bone metabolism in patients with anorexia nervosa and amenorrhoea 228
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 224
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 220
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 216
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 216
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' 212
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 211
A case of mandible Paget’s disease of the bone treated with intravenous neridronate 211
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 210
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 208
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 208
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 207
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 205
Bone involvement and osteoporosis in mastocytosis. 204
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 204
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 200
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 200
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 194
Bone involvement in patient with clonal mast cell disorders 192
Prevalence and incidence of rheumatoid arthritis in Italy. 192
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 192
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 192
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 190
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 189
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 189
Could γ\δ T-cells explain zoledronic acid adverse events? 188
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 188
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 185
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 185
Anti-TNF treatment response in rheumatoid arthritis patients with moderate disease activity: a prospective observational multicentre study (MODERATE) 184
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 184
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 183
Osteopetrosi 181
The obesity paradox and osteoporosis 180
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 178
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 174
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 173
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 172
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 171
DXA bone mineral density in males: retrospective study in real life. 169
Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis 167
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 167
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 166
Sclerostin and DKK1 in primary hyperparathyroidism. 166
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 166
Effects of denosumab on peripheral lymphocyte subpopulations 164
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 163
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome 163
The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 162
Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosis 162
Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis 162
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 161
Correction to: The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 160
Prevalence of osteoporosis in patients affected by mastocytosis 158
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 158
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 158
Suboptimal methotrexate use in rheumatoid arthritis patients in Italy: the MARI study 157
Development and First Validation of a Disease Activity Score for Gout 157
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 157
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 157
Surgical Treatment of Symptomatic Aortic Aneurysm in a Patient with Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis: Case Report and Review of the Literature 154
Periostin: The bone and beyond 154
Improvements in the management of rheumatic patients from vertebral imagee obtained through dual-energy X-ray absorptiometry. 153
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 153
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 152
Drug-induced osteonecrosis of the jaw: the state of the art 152
Relationship Between Increased Fecal Calprotectin Levels and Interstitial Lung Disease in Systemic Sclerosis 152
Psoriatic Arthritis and Diabetes Mellitus: A Narrative Review 152
Operator-independent quantitative chest computed tomography versus standard assessment of interstitial lung disease related to systemic sclerosis: A multi-centric study 151
Focal bone involvement in inflammatory arthritis: the role of IL17 149
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 149
Treatment of complex regional pain syndrome type I with neridronate: a randomized, double-blind, placebo-controlled study. 148
Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID) 148
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis 146
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 145
Predictors, Risk Factors, and Incidence Rates of Psoriatic Arthritis Development in Psoriasis Patients: A Systematic Literature Review and Meta-Analysis 145
Effects of secukinumab on serum adipocytokines: preliminary data 144
Vitamin D levels in patients with psoriasis with or without arthritis 143
Rheumatoid arthritis, γδ T cells and bisphosphonates 143
Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa 141
Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides? 141
Permanent Discontinuation of Glucocorticoids in Polymyalgia Rheumatica is Uncommon but May Be Enhanced by Amino Bisphosphonates 140
Correction to: The obesity paradox and osteoporosis 139
Duration of treatment for osteoporosis 139
Short-term effects on bone turnover markers of a single high dose of oral vitamin D₃. 138
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 138
Could nail and joint alterations make the difference between psoriatic arthritis and osteoarthritis during the ultrasonographic evaluation of the distal interphalangeal joints? 138
Vitamin D status in patients with chronic plaque psoriasis 137
Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis 137
Barnidipine as a potential alternative treatment for Raynaud's phenomenon secondary to systemic sclerosis: a retrospective pilot study 137
The negative bone effects of the disease and of chronic corticosteroid treatment in premenopausal women affected by rheumatoid arthritis 136
Quantitative chest computed tomography is associated with two prediction models of mortality in interstitial lung disease related to systemic sclerosis 136
Totale 18.121
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.363
article - articoli 88.213
book - libri 0
conference - conferenze 688
curatela - curatele 0
other - altro 462
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 178.726
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.113 0 347 7 62 54 29 24 65 81 24 85 335
2022/20232.688 191 289 242 491 213 650 45 145 291 30 76 25
2023/20241.251 54 113 107 152 158 180 60 126 6 37 189 69
2024/20253.160 152 221 152 493 145 111 163 147 472 262 282 560
2025/202611.530 720 506 1.661 1.661 2.545 710 1.060 554 791 612 267 443
2026/2027515 189 326 0 0 0 0 0 0 0 0 0 0
Totale 26.427